Latifovic, Lidija
$105,000.00 CAD
≈ 16 months of average Canadian pay
- Department
- Canadian Institutes of Health Research
- Program
- —
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- September 1, 2018 – August 31, 2021
- Reference
- cihr-irsc:236-2018-2019-Q2-00342
Published purpose
A genetic analysis of the pharmacokinetic and pharmacodynamic pathways of cetuximab; to assess efficacy and toxicity outcomes in chemotherapy-refractory, metastatic colorectal cancer patients from the Canadian Cancer Trials Group CO.20 and CO.17 trials.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions